H.C. Wainwright Thinks Asensus Surgical’s Stock is Going to Recover
May 05 2022 - 06:26AM
TipRanks
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy
rating on Asensus Surgical (ASXC – Research Report) today and set a
price target of $4.00. The company's shares closed last Wednesday
at $0.44, close to its 52-week low of $0.41. According to
TipRanks.com, Ramakanth is a 3-star analyst with an average return
of 2.8% and a 34.8% success rate. Ramakanth covers the Healthcare
sector, focusing on stocks such as Diffusion Pharmaceuticals,
Corvus Pharmaceuticals, and Janux Therapeutics Inc. Currently, the
analyst consensus on Asensus Surgical is a Moderate Buy with an
average price target of $4.00. See Insiders’ Hot Stocks on TipRanks
>> The company has a one-year high of $3.
https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-asensus-surgicals-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Jan 2023 to Feb 2023
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Feb 2022 to Feb 2023